Innovating Works

HCS Pharma

Desconocido
NANOSTEM: New nanomaterials for neural stem cells drug delivery HCS Pharma participó en un H2020: H2020-MSCA-ITN-2017 Brain conditions such as neurodegenerative diseases, stroke and traumatic injuries are a mayor burden in modern society. Because neural stem...
2017-08-30 - 2022-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.